Douglas G Postels

Dr. Douglas G Postels

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Seminars in Pediatric Neurology
Verified
Journal Article
Open access
Marko KeracMarko Kerac
Marko Kerac
DPDouglas G Postels
Douglas G Postels
MMMac Mallewa
Mac Mallewa
AJAlhaji Alusine Jalloh
Alhaji Alusine Jalloh
WVWieger P. Voskuijl
Wieger P. Voskuijl
EMElizabeth Molyneux
Elizabeth Molyneux
Malnutrition and neurodisability are both major public health problems in Africa. This review highlights key areas where they interact. This happens throughout life and starts with maternal malnutrition affecting fetal neurodevelopment with both immediate (eg, folate deficiency causing neural tube defects) and lifelong implications (eg, impaired cognitive function). Maternal malnutrition can also increase the risk of perinatal problems, including birth asphyxia, a major cause of neurologic damage and cerebral palsy. Macronutrient malnutrition can both cause and be caused by neurodisability. Mechanisms include decreased food intake, increased nutrient losses, and increased nutrient requirement. Specific micronutrient deficiencies can also lead to neurodisability, for example, blindness (vitamin A), intractable epilepsy (vitamin B6), and cognitive impairment (iodine and iron). Toxin ingestion (eg, from poorly processed cassava) can cause neurodisability including a peripheral polyneuropathy and a spastic paraparesis. We conclude that there is an urgent need for nutrition and disability programs to work more closely together.

1 December 1997 in Archives of Pediatrics & Adolescent Medicine
Verified
Journal Article
Closed access
PDF file
ABAnita L. Belman
Anita L. Belman
LRL. Reynolds
L. Reynolds
TPT. Preston
T. Preston
DPDouglas G Postels
Douglas G Postels
RGR. Grimson
R. Grimson
PCP. K. Coyle
P. K. Coyle
Objective: To determine the relative frequency of abnormal cerebrospinal fluid (CSF) findings in children with Lyme disease—associated facial nerve palsy. Design: A clinical series. A prospective evaluation was undertaken of the condition of children seen between 1988 and 1996 at a single medical center in a Lyme disease endemic area. Patients: Forty children (24 boys and 16 girls, aged 3-19 years) with new onset facial nerve palsy who met the Centers for Disease Control and Prevention case definition of Lyme disease. Interventions: Neurologic examinations. Cerebrospinal fluid analyses. Main Outcome Measures: Rates of abnormal CSF findings: white blood cell count, protein level, andBorrelia burgdorferi—specific CSF assays. Results: Cerebrospinal fluid white blood cell count, protein level, or both were abnormal in 27 (68%) of the children. Thirty-six (90%) of the 40 children had a CSF abnormality consistent with central nervous system infection or immune involvement byB burgdorferi. Of the 22 children with CSF pleocytosis, only 7 (32%) had headache and none had meningeal signs. Conclusions: Most children with Lyme disease—associated facial nerve palsy have CSF abnormalities. Our studies indicate that, in endemic areas, facial nerve palsy in children may be a marker of Lyme disease and occult meningitis. When Lyme disease is suspected, CSF should be examined; in some cases, it may be helpful to expand beyond routine CSF studies to look at a battery ofB burgdorferi—specific assays. Arch Pediatr Adolesc Med. 1997;151:1224-1228.

18 September 2012 in Neurology
Verified
Journal Article
Closed access
PDF file
DPDouglas G Postels
Douglas G Postels
TTTerrie E. Taylor
Terrie E. Taylor
MMMalcolm Molyneux
Malcolm Molyneux
KMKara Mannor
Kara Mannor
PKPeter W. Kaplan
Peter W. Kaplan
GBGretchen L. Birbeck
Gretchen L. Birbeck
Objectives: Patients surviving retinopathy-positive cerebral malaria (CM) are at high risk for the development of epilepsy, developmental disabilities, and behavioral abnormalities. We aimed to establish whether retinopathy-negative CM is also a risk factor for these outcomes. Methods: Between 2005 and 2007, survivors of CM and concurrently hospitalized controls in Blantyre, Malawi, were followed to assess the development of neurologic abnormalities. At discharge and every 3 months thereafter, incident cases of epilepsy and developmental disabilities were ascertained using screening questionnaires and confirmatory neurologic examinations. Incident cases of epilepsy and developmental disabilities were compared in retinopathy-negative CM survivors to controls and retinopathy-positive CM survivors. Results: Thirty-five retinopathy-negative CM survivors were enrolled. Their neurologic outcomes were compared to 132 retinopathy-positive CM survivors and 272 controls. Compared to survivors of retinopathy-positive CM, children without malaria retinopathy have an equal odds of adverse neurologic outcome (odds ratio [OR] = 1.0, 95% confidence interval [CI] 0.4–2.2). Eleven of 35 survivors of retinopathy-negative CM had at least 1 adverse neurologic outcome compared to 2 of 272 controls (OR 61.9, 95% CI 13.0–295.5). In retinopathy-negative CM survivors, a Blantyre Coma Scale score ≤1 on admission was associated with an adverse outcome. Conclusions: Compared with controls, children surviving either retinopathy-negative or -positive CM are at similar high risk for adverse neurologic outcomes. Studies to evaluate preventive and therapeutic strategies in children with both retinopathy-negative and -positive CM are needed to improve mortality, morbidity, or both.

1 January 2013
Verified
Book Chapter
Closed access
DPDouglas G Postels
Douglas G Postels
GBGretchen L Birbeck
Gretchen L Birbeck

1 March 2014 in Seminars in Pediatric Neurology
Verified
Journal Article
Open access
MGMelissa Gladstone
Melissa Gladstone
MMMac Mallewa
Mac Mallewa
AJAlhaji Alusine Jalloh
Alhaji Alusine Jalloh
WVWieger Voskuijl
Wieger Voskuijl
DPDouglas G Postels
Douglas G Postels
EMElizabeth Molyneux
Elizabeth Molyneux
Neurodevelopmental delay, neurodisability, and malnutrition interact to contribute a significant burden of disease in global settings. Assessments which are well integrated with plans of management or advice are most likely to improve outcomes. Assessment tools used in clinical research and programming to evaluate outcomes include developmental and cognitive tools that vary in complexity, sensitivity, and validity as well as the target age of assessment. Few tools have been used to measure socioemotional outcomes and fewer to assess the disabled child with malnutrition. There is a paucity of tools used clinically which actually provide families and professionals with advice to improve outcomes. Brain imaging, electroencephalography, audiology, and visual assessment can also be used to assess the effect of malnutrition on brain structure and function. The interaction of neurodisability and malnutrition is powerful, and both need to be considered when assessing children. Without an integrated approach to assessment and management, we will not support children and families to reach their best potential outcomes.

21 April 2022 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
KCK. Chetcuti
K. Chetcuti
CCC. Chilingulo
C. Chilingulo
MGM.S. Goyal
M.S. Goyal
LVL. Vidal
L. Vidal
NON.F. O’brien
N.F. O’brien
TTTerrie Taylor
Terrie Taylor
SUMMARY: Low-field, portable MR imaging may expedite patient management in the setting of critical illness. We successfully implemented low-field MR imaging at the Queen Elizabeth Central Hospital in Malawi; a low-resource setting. We present our experience of low-field, portable MR imaging start-up and use in Malawi; the first of its kind in Sub-Saharan Africa, together with complementary troubleshooting mechanisms that may be used especially in similar resource-constrained contexts.